A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn’s Disease

Figure 5

Forest plot of the efficacy of Infliximab in the 7 prospective trials. (a) Rates of endoscopic recurrence. (b) Rates of clinical recurrence. Green dots represent the RR of rates of endoscopic recurrence and blue dots represent the RR of rates of clinical recurrence. Horizontal lines represent 95%Cls of the RR estimates. Diamonds stand for summary effect estimate of the meta-analysis.

(a)

(b)